TIMP1 and psoriasis: Although an increased level of tissue inhibitor of metalloproteinases (TIMP-1) has been proposed as a laboratory biomarker in the diagnosis of TAK, it is poorly specific, often occurring also in psoriasis, liver fibrosis, and cancer [47].